Human Prostacyclin Synthase Gene and Hypertension

Naoharu Iwai(National Cerebral and Cardiovascular Center), Shunroku Baba(National Cerebral and Cardiovascular Center), Jun Ogata(Keio University), Toshio Ogihara(Osaka University), Tadashi Tanabe(University of the Sciences), Kazuhiko Ishikawa(National Cerebral and Cardiovascular Center), Toshifumi Mannami(National Cerebral and Cardiovascular Center), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Tomohiro Katsuya(Japan Medical Association)
Circulation
November 30, 1999
10.1161/01.cir.100.22.2231
Cited by 75

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells
|Journal of Biological Chemistry|1998|792
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485